A Landmark Victory for Public Health: Tunisia Validated by WHO for Eliminating Trachoma

In a monumental stride for global health equity, the World Health Organization (WHO) has officially validated Tunisia as having eliminated trachoma as a public health problem. This achievement marks the culmination of decades of intensive, coordinated national efforts to eradicate a disease that has long cast a shadow over the health and economic stability of vulnerable populations.

The milestone is significant not only for Tunisia but for the global community, as the country becomes the 31st nation in the world to receive this validation. Within the WHO Eastern Mediterranean Region, Tunisia now stands as the 14th country to have successfully eliminated at least one neglected tropical disease (NTD), signaling a powerful shift in the battle against preventable blindness.

For Tunisia, the journey to Tunisia trachoma elimination represents more than just a clinical success; We see a testament to the efficacy of long-term political will and the integration of specialized eye care into the broader fabric of primary healthcare. By addressing the root causes of transmission—ranging from hygiene to environmental sanitation—the nation has effectively turned a once-heavy health burden into a blueprint for success.

The Path from Endemicity to Elimination

To understand the magnitude of this achievement, one must look back at the historical burden of the disease. In the early to mid-20th century, trachoma was endemic across Tunisia, with a prevalence that affected at least half of the population. The disease was particularly devastating in the country’s southern regions, where limited access to resources exacerbated its spread.

Trachoma is caused by the bacterium Chlamydia trachomatis. It is a highly infectious condition that spreads through close personal contact, contaminated surfaces and the activity of flies that carry eye and nose discharge. If left untreated, repeated infections cause chronic inflammation that leads to irreversible scarring of the eyelids. This scarring eventually turns the eyelashes inward—a condition known as trachomatous trichiasis (TT)—which can scrape the cornea and ultimately lead to permanent blindness.

“I congratulate Tunisia on this historic public health achievement,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. “Eliminating trachoma shows what long-term political commitment, strong primary health care and teamwork can do. Tunisia has proven that even the world’s leading infectious cause of blindness can be overcome.”

Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, echoed this sentiment, noting that the achievement reflects a “sustained and consistent national commitment over many years” and demonstrates what is possible when a nation remains focused on addressing preventable causes of blindness.

The SAFE Strategy: A Multi-Pronged Defense

The success of the Tunisian campaign was anchored in the adoption and scaling of the WHO-recommended SAFE strategy. This comprehensive approach moves beyond simple medical treatment, addressing the environmental and social determinants that allow the bacterium to thrive.

• S – Surgery: Providing surgical interventions for advanced cases of trachomatous trichiasis to prevent further corneal damage and blindness.
• A – Antibiotics: Implementing mass drug administration or targeted treatment to clear the Chlamydia trachomatis infection within the population.
• F – Facial cleanliness: Promoting hygiene practices to reduce the transmission of the bacteria through direct contact.
• E – Environmental improvement: Enhancing access to safe water and improved sanitation to eliminate the breeding grounds for flies and reduce the spread of infection.

Tunisia’s strategy was not limited to these four pillars. The Ministry of Health integrated eye care into school health programs and nationwide screening campaigns, ensuring that care reached even the most remote communities. This was bolstered by significant progress in water and sanitation coverage, which fundamentally altered the landscape of disease transmission.

“Validation marks a historic achievement for Tunisia and reflects our country’s long-standing commitment to public health, prevention and equity,” said Dr. Mustapha Ferjani, Tunisia’s Minister of Health. He emphasized that the milestone was the result of “decades of coordinated national efforts, with the dedication of generations of health-care professionals [and] local communities who worked tirelessly to expand access to care.”

Defining Success: The Epidemiological Thresholds

In the realm of public health, “elimination” is not a vague term; it is defined by rigorous epidemiological criteria. For Tunisia to receive WHO validation, the country had to meet strict prevalence thresholds across its formerly endemic districts.

The criteria for the elimination of trachoma as a public health problem include:

1. A prevalence of trachomatous trichiasis (TT) that is “unknown to the health system” of less than 0.2% among individuals aged 15 years and older.
2. A prevalence of trachomatous inflammation-follicular (TF) in children aged 1–9 years of less than 5%.
3. The existence of a robust, functioning system to identify and manage any new incident cases of TT.

Meeting these benchmarks required extensive, high-quality surveillance and data collection to ensure that the disease had truly been pushed below the threshold of community transmission.

The Global Context: Fighting Neglected Tropical Diseases

Trachoma is categorized as a neglected tropical disease (NTD), a group of conditions that disproportionately affect impoverished communities in tropical and subtropical regions. These diseases often carry devastating social and economic consequences, trapping populations in cycles of poverty due to the disability and loss of productivity they cause.

The fight against trachoma is a central component of the WHO road map for neglected tropical diseases 2021–2030. While the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020) set ambitious early goals, the global target has now been extended to 2030. Tunisia’s success serves as a vital proof of concept for other nations working toward the health-related Sustainable Development Goals.

Tunisia joins an elite group of countries that have already achieved this milestone, including Algeria, Egypt, Morocco, and many others across Africa, Asia, and the Americas. Each successful validation strengthens the global momentum required to meet the 2030 targets.

“The validation of elimination of trachoma as a public health problem in Tunisia reflects the impact of sustained collaboration between the Ministry of Health and WHO,” said Dr. Ahmed Zouiten, Acting WHO Representative in Tunisia. He noted that the achievement stands as a “strong demonstration of how science, evidence-based programming and coordinated technical support can overcome neglected tropical diseases every time and everywhere.”

Looking Ahead: Preventing Resurgence

While the validation is a moment for celebration, the work of public health officials is far from over. The primary risk following elimination is the potential resurgence of the disease if hygiene standards slip or if surveillance systems fail to detect imported cases.

To mitigate this, Tunisia has implemented a robust post-validation surveillance system. This system is designed to detect any return of the disease at an early stage, ensuring that incident cases of trachomatous trichiasis are managed immediately through ongoing case management and the continuous training of health professionals.

As Tunisia moves forward, the focus shifts from mass intervention to the maintenance of high-level sanitation, sustained primary healthcare, and vigilant monitoring. The goal is to ensure that the generations to come are born into a country where preventable blindness is a relic of the past.

Frequently Asked Questions

What is trachoma?

Trachoma is a bacterial eye infection caused by Chlamydia trachomatis. It is a leading infectious cause of blindness worldwide, spreading through close contact and poor sanitation.

How does trachoma cause blindness?

Repeated infections lead to scarring of the inner eyelid. This causes the eyelashes to turn inward (trachomatous trichiasis), which repeatedly scrapes the cornea, leading to permanent scarring and vision loss.

What does “elimination” mean in this context?

Elimination means the disease prevalence has fallen below specific, scientifically defined thresholds (less than 0.2% for advanced cases in adults and less than 5% for inflammation in children) and that a system exists to manage any new cases.

What is the SAFE strategy?

It is a four-part public health approach: Surgery for advanced cases, Antibiotics to treat infection, Facial cleanliness to reduce spread, and Environmental improvement to improve water and sanitation.

The next major checkpoint for this initiative will be the ongoing monitoring and reporting conducted through Tunisia’s newly established post-validation surveillance system.

What are your thoughts on this public health milestone? Does this success story offer hope for other neglected tropical diseases? Share this article and join the conversation in the comments below.